Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
J.P. Morgan Healthcare Conference
Pharma
Bayer projects $3B sales potential each for Kerendia, Nubeqa
Bayer raised its peak sales projection for its heart medication Kerendia and prostate cancer treatment Nubeqa to 3 billion euros ($3.2 billion) each.
Kevin Dunleavy
Jan 10, 2023 4:20pm
Takeda expands manufacturing in preparation for Qdenga launch
Jan 10, 2023 10:17am
Eylea sales disappoint in Q4, Regeneron says its a 'blip'
Jan 9, 2023 3:15pm
Sayonara, San Francisco. #JPM22 is moving to virtual
Dec 15, 2021 9:53am
GlaxoSmithKline CEO reshuffles 40% of management team
Jan 9, 2018 10:10am
AbbVie chief joins the 10% price-hike pledge
Jan 12, 2017 9:53am
